$RNXT Q2 '26 Earnings Results & Recap
• Reported GAAP EPS of -$0.06 up 25.00% YoY
• Reported revenue of $0.91M up 115.40% YoY
• RenovoRx raised and tightened its full-year 2026 revenue guidance to a range of $3.75 million to $4.25 million, up from the prior range of $3.0 million to $4.0 million.